French Government to consider banning Optical Advertising

There was much discussion around SILMO 26 about the threat of the banning of optical advertising in France. We investgated how this might affect the Optical Industry, could it happen in other parts of Europe or indeed the UK and its devolved health regions.

One important point of context is that, as of September 2026, this appears to be a proposed restriction rather than a completed general ban. A draft presented by the French administration in September 2026 would prohibit advertising for reimbursed optical and hearing-aid equipment; the precise scope and final status remain subject to the government’s process.

The pros and cons of restricting advertising for optical and audiology products in France

Advertising Restrictions in Optical and Audiology

The French authorities’ proposal to restrict advertising for optical and audiology products raises an interesting question about where the boundary should lie between healthcare and commercial activity. Glasses and hearing aids are, on the one hand, essential products that help people to see, hear and participate fully in everyday life. On the other hand, they are also products sold in a competitive commercial market. Restricting their advertising could therefore have both positive and negative consequences for patients, professionals and businesses.

One argument in favour of the proposed restriction is that it could help to reduce the commercialisation of healthcare. Advertising can sometimes encourage consumers to think of medical devices as ordinary consumer goods, where attractive offers, discounts or promotional campaigns become more important than clinical need. This concern has previously been raised particularly in relation to hearing aids, where the French Government has emphasised the importance of objective, clear and transparent information for patients. Existing French rules already require medical-device advertising to be objective and not misleading.

A restriction could also help protect vulnerable consumers. People experiencing hearing loss or deteriorating vision may be particularly dependent on professional advice. Excessively persuasive advertising could potentially encourage people to focus on price or promotional offers rather than the suitability of the product and the quality of professional care. In audiology, for example, the fitting and ongoing adjustment of a hearing aid are important parts of the service, rather than simply the purchase of a device. Previous French health-sector discussions have highlighted the importance of professional guidance and the risks associated with inappropriate or insufficiently personalised equipment.

Another possible advantage is that a reduction in advertising could lessen competitive pressure based purely on marketing. Large chains with substantial advertising budgets may have greater resources to promote themselves than smaller independent practices. In theory, restricting advertising could place greater emphasis on professional reputation, clinical service and patient care rather than the size of a company’s marketing budget.

However, there are also significant disadvantages.

Perhaps the most important is that advertising can provide useful information. Consumers may learn about available products, prices, services and the existence of different providers through advertising. The French Government itself has previously recognised the importance of patients receiving clear and transparent information about hearing products and associated services.

This is particularly relevant in relation to affordability. Optical and hearing products can represent significant expenditure, even where reimbursement schemes are available. Advertising can make consumers aware of price differences and special offers, allowing them to compare providers. The Rassemblement des Opticiens de France has argued that a complete advertising ban could reduce consumers’ ability to compare prices and weaken competition between providers. This is the position of a professional organisation and should therefore be regarded as an industry perspective rather than an established fact.

There is also a potential impact on smaller businesses. Advertising is one way for an independent optician or audiology practice to establish its presence and attract new patients or customers. If advertising is heavily restricted, established companies with strong reputations and existing customer bases may have an advantage because they already have name recognition. This creates an interesting tension: a policy intended to reduce commercial pressure could potentially make competition more difficult for some smaller providers.

The question is therefore not simply whether advertising is good or bad. The more important question may be what kind of advertising should be permitted. French legislation already provides a framework requiring medical-device advertising to be objective, to promote appropriate use and not to create risks to public health. Existing professional rules also allow certain forms of neutral, objective and educational communication in optical care.

A possible middle ground would therefore be to distinguish between information and persuasion. Information about prices, opening hours, available services, technology and reimbursement could arguably remain available, while advertising that makes exaggerated medical claims or encourages unnecessary consumption could be more strictly controlled. This approach could preserve consumer choice while reducing the risk of misleading or overly aggressive commercial practices.

Ultimately, the debate reflects a wider issue in modern healthcare: patients are also consumers, but healthcare products cannot always be treated in the same way as ordinary consumer goods. A pair of glasses or a hearing aid may have a commercial price, but it also serves an important health function. Any restriction on advertising therefore needs to balance patient protection, access to information, affordability, professional ethics and fair competition.

Our reflection is that the strongest case is not necessarily for eliminating advertising altogether, but for ensuring that advertising in these sectors remains responsible, factual and genuinely useful to patients. The challenge for the French authorities will be to protect people from misleading commercial pressure without unintentionally reducing the information and competition that can also benefit consumers.

In the UK we have the benefit of the regulatory body (the GOC) whose job is to protect the public from false claims and illegal supplies, whether the Hearing Aid Council has the same powers and has the teeth to use them remains open to debate.

In our opinion this kind of debate could only happen in France where the debate over Optometrists, Opticiens and Ophthalmologists still grinds on creating huge delays in on-time eyecare.